CHERYL MARBELLA: Open Payments
NPI 1437234705 · JEFFERSON HILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 41 payments from 14 companies in 2025. Trend: 2023 $522 · 2024 $351 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $180 |
| E.R. Squibb & Sons, L.L.C. | 6 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| PFIZER INC. | 3 | $67 |
| Novo Nordisk Inc | 4 | $63 |
| HEARTFLOW, INC. | 2 | $58 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| SCPHARMACEUTICALS INC. | 3 | $50 |
| Amgen Inc. | 2 | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $29 |
Products named: LEQVIO, Kerendia, ELIQUIS, VYNDAQEL, Wegovy, FFRct, NEXLETOL, FUROSCIX.
Industry payments across PA — which companies pay providers there.
